Bleeding Complications in Patients Undergoing Intrathecal Drug Delivery System Implantation | Zendy

Nafisseh S. Warner | Zendy; Markus A. Bendel | Zendy; Matthew A. Warner | Zendy; Jacob J. Strand | Zendy; Halena M. Gazelka | Zendy; Bryan C. Hoelzer | Zendy; William D. Mauck | Zendy; Tim J. Lamer | Zendy; Daryl J. Kor | Zendy; Susan M. Moeschler | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Bleeding Complications in Patients Undergoing Intrathecal Drug Delivery System Implantation

Author(s) -

Nafisseh S. Warner,

Markus A. Bendel,

Matthew A. Warner,

Jacob J. Strand,

Halena M. Gazelka,

Bryan C. Hoelzer,

William D. Mauck,

Tim J. Lamer,

Daryl J. Kor,

Susan M. Moeschler

Publication year - 2017

Publication title -

pain medicine

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 0.893

H-Index - 97

eISSN - 1526-4637

pISSN - 1526-2375

DOI - 10.1093/pm/pnw363

Subject(s) - medicine , discontinuation , aspirin , antithrombotic , concomitant , complication , anesthesia , antiplatelet drug , surgery , incidence (geometry) , retrospective cohort study , anticoagulant , analgesic , neurovascular bundle , clopidogrel , optics , physics

Intrathecal drug delivery systems (IDDSs) have dramatically improved analgesia and the functional status of cancer patients and those with chronic pain states. However, given the close proximity to the neuraxis and frequent concomitant use of antiplatelet or anticoagulant medications, this intervention is not without risk. The goal of this investigation was to determine the incidence of bleeding complications following IDDS placement.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research